Threatened abortion and its consequences on maternal and fetal health

Salma Akter Munmun1, Rowson Ara1, Sabiha Islam1

  • 1Department of Obstetrics and Gynecology, Bangladesh Medical University (BMU), Dhaka, Bangladesh, South Asia.

Bioinformation
|March 30, 2026
PubMed

Threatened abortion, defined as vaginal bleeding in the first trimester of pregnancy with a viable fetus, is a common obstetric complication. Therefore, it is of interest to investigate the maternal and fetal health outcomes associated with threatened abortion and to compare these outcomes with a control group of healthy pregnancies. Hence, a total of 240 pregnant women were included in this study, with 120 women diagnosed with threatened abortion and 120 healthy controls. Women with threatened abortion showed significantly higher rates of preterm delivery (25% vs. 12.5%, p<0.001), low birth weight (23.33% vs. 10%, p<0.001) and intrauterine growth restriction (12.5% vs. 6.67%) compared to the control group. Additionally, the incidence of antepartum hemorrhage (9.17% vs. 3.33%, p=0.001) and postpartum hemorrhage (10% vs. 4.17%) were significantly higher in the threatened abortion group. Neonatal outcomes also showed higher rates of low Apgar scores (10% vs. 3.33%, p<0.001) and NICU admissions (28.33% vs. 6.67%). Our study highlights the significant risks associated with threatened abortion, including increased rates of preterm birth, low birth weight, fetal growth restriction and maternal complications. These findings emphasize the need for early identification and careful management of pregnancies complicated by threatened abortion.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
74.1K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.2K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
532